Exploring the evidence base for national and regional policy interventions to combat resistance

The Lancet

Volumn 387, Issue 10015, 2016, Pages 285-295

  Dar, Osman A ^a,b   Hasan, Rumina ^c   Schlundt, Jørgen ^d   Harbarth, Stephan ^e   Caleo, Grazia ^f   Dar, Fazal K ^g   Littmann, Jasper ^h   Rweyemamu, Mark ⁱ   Buckley, Emmeline J ^j   Shahid, Mohammed ^k   Kock, Richard ^l   Li, Henry Lishi ^j   Giha, Haydar ^g   Khan, Mishal ^j,m   So, Anthony D ⁿ   Bindayna, Khalid M ^g   Kessel, Anthony ^j   Pedersen, Hanne Bak ^o   Permanand, Govin ^o   Zumla, Alimuddin ^p,q   Røttingen, John Arne ^r,s,t   Heymann, David L ^a,b,j   more..

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ROYAL INSTITUTE OF INTERNATIONAL AFFAIRS   (United Kingdom)

^c AGA KHAN UNIVERSITY   (Pakistan)

^d Nanyang Technological University   (Singapore)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f MÉDECINS SANS FRONTIÈRES   (Switzerland)

^g ARABIAN GULF UNIVERSITY   (Bahrain)

^h UNIVERSITY OF KIEL   (Germany)

ⁱ SOKOINE UNIVERSITY OF AGRICULTURE   (Tanzania)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^k ALIGARH MUSLIM UNIVERSITY   (India)

^l ROYAL VETERINARY COLLEGE   (United Kingdom)

^m Research Alliance for Advocacy and Development (RAAD)   (Pakistan)

ⁿ DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^p UNIVERSITY COLLEGE LONDON   (United Kingdom)

^q UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^r NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^s HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^t UNIVERSITY OF OSLO   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH EDUCATION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; PRIORITY JOURNAL; ANIMAL; ANIMAL HUSBANDRY; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH PROMOTION; ORGANIZATION AND MANAGEMENT; PROCEDURES; PROGRAM EVALUATION; STANDARDS;

ANIMAL HUSBANDRY; ANIMALS; ANTI-BACTERIAL AGENTS; DELIVERY OF HEALTH CARE; DRUG RESISTANCE, BACTERIAL; EVIDENCE-BASED MEDICINE; HEALTH CARE REFORM; HEALTH POLICY; HEALTH PROMOTION; HUMANS; INFECTION CONTROL; PROGRAM EVALUATION;

EID: 84954373339     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00520-6     Document Type: Review

References (101)

1. The One Health Initiative http://www.onehealthinitiative.com/ (accessed July 2, 2014).
2. Ministry of Health Welfare and Sport The Netherlands The benefits of responsible use of medicines. Setting policies for better and cost effective healthcare 2012 Ministry of Health, Welfare and Sport Amsterdam http://apps.who.int/medicinedocs/documents/s19989en/s19989en.pdf (accessed Sept 29, 2015).
3. B Huttner, H Goossens, T Verheij, S Harbarth the CHAMP consortium Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries Lancet Infect Dis 10 2010 17 31
4. B Huttner, S Harbarth, D Nathwani the ESCMID Study Group for Antibiotic Policies (ESGAP) Success stories of implementation of antimicrobial stewardship: a narrative review Clin Microbiol Infect 20 2014 954 962
5. Public Health England UK Department of Health Behaviour change and antibiotic prescribing in healthcare settings 2015 UK Department of Health London
6. JS Gerber, PA Prasad, AG Fiks et al. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial JAMA 309 2013 2345 2352
7. EA Belongia, BJ Sullivan, P-H Chyou, E Madagame, KD Reed, B Schwartz A community intervention trial to promote judicious antibiotic use and reduce penicillin-resistant Streptococcus pneumoniae carriage in children Pediatrics 108 2001 575 583
8. TW Hennessy, KM Petersen, D Bruden et al. Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: a controlled intervention trial in rural Alaska Clin Infect Dis 34 2002 1543 1550
9. JA Finkelstein, SS Huang, K Kleinman et al. Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts Pediatrics 121 2008 e15 e23
10. SR Ranji, MA Steinman, KG Shojania, R Gonzales Interventions to reduce unnecessary antibiotic prescribing: a systematic review and quantitative analysis Med Care 46 2008 847 862
11. P Little, M Moore, J Kelly the PIPS Investigators Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial BMJ 348 2014 g1606
12. GK Spurling, CB Del Mar, L Dooley, R Foxlee, R Farley Delayed antibiotics for respiratory infections Cochrane Database Syst Rev 4 2013 CD004417.
13. P Davey, E Brown, E Charani et al. Interventions to improve antibiotic prescribing practices for hospital inpatients Cochrane Database Syst Rev 4 2013 CD003543.
14. MS Khan, S Salve, JD Porter Engaging for-profit providers in TB control: lessons learnt from initiatives in South Asia Health Policy Plan 2015 10.1093/heapol/czu137 published online Jan 20.
15. S Earnshaw, G Mancarella, A Mendez et al. European Antibiotic Awareness Day: a five-year perspective of Europe-wide actions to promote prudent use of antibiotics Euro Surveill 19 2014 20928
16. J Vanden Eng, R Marcus, JL Hadler et al. Consumer attitudes and use of antibiotics Emerg Infect Dis 9 2003 1128 1135
17. S Coenen, B Gielen, A Blommaert, P Beutels, N Hens, H Goossens Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures J Antimicrob Chemother 69 2014 529 534
18. CA McNulty, P Boyle, T Nichols, P Clappison, P Davey The public's attitudes to and compliance with antibiotics J Antimicrob Chemother 60 suppl 1 2007 i63 i68
19. Eurosurveillance editorial team Fifth European Antibiotic Awareness Day on 18 November: joining forces to reduce antibiotic resistance Euro Surveill 17 2012 20314
20. EA Belongia, B Schwartz Strategies for promoting judicious use of antibiotics by doctors and patients BMJ 317 1998 668 671
21. AC Cheng, J Turnidge, P Collignon, D Looke, M Barton, T Gottlieb Control of fluoroquinolone resistance through successful regulation, Australia Emerg Infect Dis 18 2012 1453 1460
22. Y Xiao, J Zhang, B Zheng, L Zhao, S Li, L Li Changes in Chinese policies to promote the rational use of antibiotics PLoS Med 10 2013 e1001556
23. The management provision for clinical application of antibiotics National Health and Family Planning Commission, China. April 24, 2012 http://www.gov.cn/flfg/2012-05/08/content-2132174.htm (accessed June 20, 2014; in Chinese).
24. J Parry Former head of GSK China is charged with bribery BMJ 348 2014 g3356
25. A Jack, P Waldmeir GSK China probe flags up wider concerns Financial Times Dec 17, 2013 http://www.ft.com/cms/s/0/ba26aa2c-6648-11e3-aa10-00144feabdc0.html#axzz3nEKVZSAx (accessed Sept 30, 2015).
26. India's Sun Pharma shares sink on US FDA import ban Financial Times http://www.ft.com/cms/s/0/89ecfbc2-aa86-11e3-9fd6-00144feab7de.html#axzz35Pba4kB0 March 13, 2014 (accessed June 2, 2014).
27. Life imprisonment for Indians shipping fake drugs to Nigeria Live TD. March 30, 2011 http://www.thisdaylive.com/articles/life-imprisonment-for-indians-shipping-fake-drugs-to-nigeria/88697/ (accessed March 23, 2015).
28. FM Aarestrup, VF Jensen, HD Emborg, E Jacobsen, HC Wegener Changes in the use of antimicrobials and the effects on productivity of swine farms in Denmark Am J Vet Res 71 2010 726 733
29. ECDC Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Antimicrobial resistance surveillance in Europe 2009 2010 ECDC Stockholm
30. WHO Critically important antimicrobials for human medicine, 3rd revision 2011 World Health Organization Geneva http://www.who.int/foodsafety/publications/antimicrobials-third/en/ (accessed Sept 30, 2015).
31. WHO Impacts of antimicrobial growth promoter termination in Denmark. The WHO international review panel's evaluation of the termination of the use of antimicrobial growth promoters in Denmark 2002 World Health Organization Foulum http://apps.who.int/iris/bitstream/10665/68357/1/WHO-CDS-CPE-ZFK-2003.1.pdf (accessed Sept 30, 2015).
32. AM Hammerum, OE Heuer, HD Emborg et al. Danish integrated antimicrobial resistance monitoring and research program Emerg Infect Dis 13 2007 1632 1639
33. K Grave, HC Wegener Comment on: veterinarians' profit on drug dispensing Prev Vet Med 77 2006 306 308
34. DC Speksnijder, DJ Mevius, CJ Bruschke, JA Wagenaar Reduction of veterinary antimicrobial use in the Netherlands. The Dutch success model Zoonoses Public Health 62 suppl 1 2015 79 87
35. TR Grasswitz, TJ Leyland, JT Musiime, SJ Owens, KR Sones The veterinary pharmaceutical industry in Africa: a study of Kenya, Uganda and South Africa 2004 AU IBAR Nairobi
36. JN Moyane, AIO Jideani, OA Aiyegoro Antibiotics usage in food-producing animals in South Africa and impact on human: antibiotic resistance Afr J Microbiol Res 7 2013 2990 2997
37. N Viberg, W Kalala, P Mujinja, G Tomson, CS Lundborg "Practical knowledge" and perceptions of antibiotics and antibiotic resistance among drugsellers in Tanzanian private drugstores BMC Infect Dis 10 2010 270
38. CF Amábile-Cuevas Global perspectives of antibiotic resistance A de J Sosa DK Byarugaba C Amabile P-R Hsueh S Kariuki IN Okeke Antimicrobial resistance in developing countries 2010 Springer-Verlag New York, NY 3 13
39. O Komolafe Antibiotic resistance in bacteria-an emerging public health problem Malawi Med J 15 2004 63 67
40. IN Okeke, KK Ojo Antimicrobial resistance and use in Africa A de J Sosa DK Byarugaba C Amabile P-R Hsueh S Kariuki IN Okeke Antimicrobial resistance in developing countries 2010 Springer-Verlag New York, NY 301 314
41. A Catley, T Leyland, JC Mariner et al. Para-veterinary professionals and the development of quality, self-sustaining community-based services. Why community-based animal health workers are appropriate Rev Sci Tech 23 2004 225 252
42. V Ahuja, E Redmond Livestock services and the poor Trop Anim Health Prod 36 2004 247 268
43. A Catley, T Leyland Community participation and the delivery of veterinary services in Africa Prev Vet Med 49 2001 95 113
44. The APUA Global Mission: "Preserving the Power of Antibiotics"® and increasing access to needed drugs Alliance for the Prudent Use of Antibiotics (APUA) http://www.tufts.edu/med/apua/about-us/what-we-do.shtml 2014 (accessed Oct 22, 2015).
45. Union of Concerned Scientists The preservation of antibiotics for medical treatment act http://www.ucsusa.org/sites/default/files/legacy/assets/documents/food-and-agriculture/pamta-endorsers-by-sector.pdf 2013 (accessed Sept 30, 2015).
46. Preservation of Antibiotics for Medical Treatment Act (PAMTA) - H.R.1150 2014 American Veterinary Medical Association Washington, DC https://www.avma.org/Advocacy/National/Documents/IB-PAMTA-4-1-2014.pdf (accessed July 7, 2014).
47. Preservation of Antibiotics for Medical Treatment Act of 2013 (H.R. 1150) https://www.govtrack.us/congress/bills/113/hr1150#summary 2014 (accessed June 22, 2014).
48. E Silverman Senators introduce a bill to fight overuse of antibiotics in livestock The Wall Street Journal March 3, 2015 http://blogs.wsj.com/pharmalot/2015/03/03/senators-introduce-a-bill-to-fight-overuse-of-antibiotics-in-livestock/ (accessed Sept 30, 2015).
49. L Baertlein, PJ Huffstutter KFC faces pressure after McDonald's says no antibiotics in chicken Reuters March 12, 2015 http://www.reuters.com/article/2015/03/12/us-usa-antibiotics-yum-insight-idUSKBN0M80B720150312 (accessed March 23, 2015).
50. A Katakweba, M Mtambo, J Olsen, A Muhairwa Awareness of human health risks associated with the use of antibiotics among livestock keepers and factors that contribute to selection of antibiotic resistance bacteria within livestock in Tanzania Livest Res Rural Dev 24 2012 170
51. WHO Infection control http://www.who.int/topics/infection-control/en/ 2014 (accessed June 22, 2014).
52. G Fätkenheuer, B Hirschel, S Harbarth Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, non-sense, and evidence Lancet 385 2014 1146 1149
53. W Zingg, A Holmes, M Dettenkofer the systematic review and evidence-based guidance on organization of hospital infection control programmes (SIGHT) study group Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus Lancet Infect Dis 15 2015 212 224
54. B Allegranzi, A Gayet-Ageron, N Damani et al. Global implementation of WHO's multimodal strategy for improvement of hand hygiene: a quasi-experimental study Lancet Infect Dis 13 2013 843 851
55. G Bushnell, F Mitrani-Gold, LM Mundy Emergence of New Delhi metallo-β-lactamase type 1-producing enterobacteriaceae and non-enterobacteriaceae: global case detection and bacterial surveillance Int J Infect Dis 17 2013 e325 e333
56. MT Ogan, DE Nwiika Studies on the ecology of aquatic bacteria of the lower Niger Delta: multiple antibiotic resistance among the standard plate count organisms J Appl Bacteriol 74 1993 595 602
57. H De Boeck, B Miwanda, O Lunguya-Metila et al. ESBL-positive Enterobacteria isolates in drinking water Emerg Infect Dis 18 2012 1019 1020
58. J Mandal, V Sangeetha, V Ganesan et al. Third-generation cephalosporin-resistant Vibrio cholerae, India Emerg Infect Dis 18 2012 1326 1328
59. P Crowther-Gibson, C Cohen, K Klugman et al. Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, 2003-2008: the pre-vaccine era in a high HIV prevalence setting Antimicrob Agents Chemother 56 2012 5088 5095
60. O Mitj, R Hays, A Ipai et al. Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial Lancet 379 2012 342 347
61. R Dagan Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae Clin Microbiol Infect 15 Suppl 3 2009 16 20
62. MW Pletz Pneumococcal vaccine: protection of adults and reduction of antibiotic resistance by vaccination of children with a conjugated vaccine Med Monatsschr Pharm 34 2011 201 205 (in German).
63. J Song, R Dagan, K Klugman, B Fritzell The relationship between pneumococcal serotypes and antibiotic resistance Vaccine 30 2012 2728 2737
64. D Pittet Clean Care is Safer Care. Geneva: World Health Organization http://www.who.int/gpsc/pittet-message/en/ (accessed July 9, 2014).
65. GAVI Alliance Country eligibility policy http://www.gavialliance.org/about/governance/programme-policies/country-eligibility/ (accessed Aug 8, 2014).
66. The Global Fund to Fight AIDS, Tuberculosis and Malaria http://www.theglobalfund.org/en/malaria/ 2014 (accessed July 9, 2014).
67. Water Partnership Program World Bank Group http://water.worldbank.org/wpp (accessed Oct 22, 2015).
68. UNFPA Empowering women to protect themselves: promoting the female condom in Zimbabwe http://www.unfpa.org/news/empowering-women-protect-themselves-promoting-female-condom-zimbabwe July 1, 2010 (accessed Jan 15, 2015).
69. DE Radley Infection and treatment method of immunization against theileriosis AD Irvin MP Cunningham AS Young Advances in the control of theileriosis 1981 Martinus Nijhoff Publishers Hague 227 237
70. OE Heuer, H Kruse, K Grave, P Collignon, I Karunasagar, FJ Angulo Human health consequences of use of antimicrobial agents in aquaculture Clin Infect Dis 49 2009 1248 1253
71. A Aidara-Kane Tackling antimicrobial resistance globally: WHO's initiatives 2014 Regional Office for the Americas of the World Health Organization Washington, DC
72. The World Bank People, Pathogens and our Planet. The Economics of One Health 2012 The World Bank Washington, DC http://documents.worldbank.org/curated/en/2012/06/16360943/people-pathogens-planet-economics-one-health (accessed Sept 30, 2015).
73. The One Health Concept: Bringing Together Human and Animal Health for New Solutions (Round 12) Bill & Melinda Gates Foundation http://www.grandchallenges.org/Explorations/Topics/Pages/OneHealthRound12.aspx 2013 (accessed June 20, 2014).
74. GS Simonsen, JW Tapsall, B Allegranzi, EA Talbot, S Lazzari The antimicrobial resistance containment and surveillance approach - a public health tool Bull World Health Organ 82 2004 928 934
75. A Versporten, G Bolokhovets, L Ghazaryan the WHO/Europe-ESAC Project Group Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe Lancet Infect Dis 14 2014 381 387
76. WHO Evaluating the costs and benefits of national surveillance and response systems: methodologies and options 2005 World Health Organization Geneva http://www.who.int/csr/resources/publications/surveillance/WHO-CDS-EPR-LYO-2005-25.pdf (accessed Jan 14, 2015).
77. S Harbarth, AD Harris, Y Carmeli, MH Samore Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli Clin Infect Dis 33 2001 1462 1468
78. A Versporten, M Sharland, J Bielicki, N Drapier, V Vankerckhoven, H Goossens the ARPEC Project Group Members The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide Pediatr Infect Dis J 32 2013 e242 e253
79. IN Okeke, KP Klugman, ZA Bhutta et al. Antimicrobial resistance in developing countries. Part II: strategies for containment Lancet Infect Dis 5 2005 568 580
80. G Vernet, C Mary, DM Altmann et al. Surveillance for antimicrobial drug resistance in under-resourced countries Emerg Infect Dis 20 2014 434 441
81. K Holloway, E Mathai, A Gray the Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings Project Group Surveillance of antimicrobial resistance in resource-constrained settings - experience from five pilot projects Trop Med Int Health 16 2011 368 374
82. SE Mshana, M Matee, M Rweyemamu Antimicrobial resistance in human and animal pathogens in Zambia, Democratic Republic of Congo, Mozambique and Tanzania: an urgent need of a sustainable surveillance system Ann Clin Microbiol Antimicrob 12 2013 28
83. WHO WHO HIV drug resistance report 2012 2012 World Health Organization Geneva http://apps.who.int/iris/bitstream/10665/75183/1/9789241503938-eng.pdf (accessed June 25, 2014).
84. WHO World malaria report 2013 2013 World Health Organization Geneva http://www.who.int/malaria/publications/world-malaria-report-2013/report/en/ (accessed June 25, 2014).
85. TA Datema, L Oskam, MF Engelberts et al. Global laboratory initiative tool for a stepwise process towards tuberculosis laboratory accreditation Int J Tuberc Lung Dis 16 2012 704 705
86. H Grundmann, KP Klugman, T Walsh et al. A framework for global surveillance of antibiotic resistance Drug Resist Updat 14 2011 79 87
87. R Nisi, N Brink, F Diaz, G Moulin Antimicrobial use in animals: analysis of the OIE survey on monitoring of the quantities of antimicrobial agents used in animals 2013 World Organisation for Animal Health Paris http://www.oie.int/eng/A-AMR2013/Presentations/S2-4-Fran%C3%A7oisDiaz.pdf (accessed Sept 30, 2015).
88. Danish Veterinary and Food Administration The Yellow Card Initiative on Antibiotics http://www.foedevarestyrelsen.dk/english/Animal/AnimalHealth/Pages/The-Yellow-Card-Initiative-on-Antibiotics.aspx 2012 (accessed Jan 12, 2015).
89. EMA Trends in the sales of veterinary antimicrobial agents in nine European countries (2005-2009) 2011 European Medicines Agency London http://www.ema.europa.eu/docs/en-GB/document-library/Report/2011/09/WC500112309.pdf (accessed June 25, 2014).
90. K Grave, J Torren-Edo, A Muller, C Greko, G Moulin, D Mackay the ESVAC Group Variations in the sales and sales patterns of veterinary antimicrobial agents in 25 European countries J Antimicrob Chemother 69 2014 2284 2291
91. S Kariuki, G Revathi, J Kiiru, B Lowe, JA Berkley, CA Hart Decreasing prevalence of antimicrobial resistance in non-typhoidal Salmonella isolated from children with bacteraemia in a rural district hospital, Kenya Int J Antimicrob Agents 28 2006 166 171
92. E Vlieghe, MF Phoba, JJ Tamfun, J Jacobs Antibiotic resistance among bacterial pathogens in Central Africa: a review of the published literature between 1955 and 2008 Int J Antimicrob Agents 34 2009 295 303
93. IN Okeke, R Laxminarayan, ZA Bhutta et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status Lancet Infect Dis 5 2005 481 493
94. E Marti, J Jofre, JL Balcazar Prevalence of antibiotic resistance genes and bacterial community composition in a river influenced by a wastewater treatment plant PLoS One 8 2013 e78906
95. K Kümmerer Resistance in the environment J Antimicrob Chemother 54 2004 311 320
96. B Allegranzi, S Bagheri Nejad, C Combescure et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis Lancet 377 2011 228 241
97. FM Aarestrup, EW Brown, C Detter et al. Integrating genome-based informatics to modernize global disease monitoring, information sharing, and response Emerg Infect Dis 18 2012 e1
98. NICE Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use 2015 National Institute for Health and Care Excellence London http://www.nice.org.uk/guidance/ng15/chapter/4-Other-information (accessed March 15, 2015).
99. NICE Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use 2015 National Institute for Health and Care Excellence London http://www.nice.org.uk/guidance/ng15/evidence/full-guideline-74002861 (accessed March 15, 2015).
100. J Luoto, MA Maglione, B Johnsen et al. A comparison of frameworks evaluating evidence for global health interventions PLoS Med 10 2013 e1001469
101. G Walt, J Shiffman, H Schneider, SF Murray, R Brugha, L Gilson 'Doing' health policy analysis: methodological and conceptual reflections and challenges Health Policy Plan 23 2008 308 317